SUVEN LIFE SCIENCES

Suven Life Sciences Limited, a research-based biopharmaceutical company, designs, manufactures, and supplies bulk actives, drug intermediates, and fine chemicals for the life science industry worldwide. It provides advanced intermediates, intermediates, and active pharmaceutical ingredients. The company also offers contract research and manufacturing services, including development and supply of pharmaceutical and agro chemical intermediates for new chemical entities.
SUVEN LIFE SCIENCES
Social Links:
Industry:
Biotechnology Health Care Life Science Manufacturing Pharmaceutical
Founded:
1989-01-01
Address:
Hyderabad, Andhra Pradesh, India
Country:
India
Website Url:
http://www.suven.com
Total Employee:
101+
Status:
Active
Contact:
(914) 023-5411
Email Addresses:
[email protected]
Total Funding:
32 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF SSL By Default HSTS Microsoft Exchange Online Office 365 Mail Microsoft DNS
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Beijing CoSci Med-Tech
Beijing CoSci Med-Tech Co.,Ltd, is a newly developed the research of the pharmaceutical company
BioInvent
BioInvent is a research-based pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
MiLab LifeSciences
MiLab LifeSciences is a research-based pharmaceutical company.
Minophagen Pharmaceutical
Minophagen Pharmaceutical is a research-based pharmaceutical enterprise
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Theragen Bio
Theragen Bio is a genome service provider and AI-based biopharmaceutical company.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.suven.com Semrush global rank: 7 M Semrush visits lastest month: 943
- Host name: 183.82.125.49.actcorp.in
- IP address: 183.82.125.49
- Location: Hyderabad India
- Latitude: 17.3846
- Longitude: 78.4574
- Timezone: Asia/Kolkata
- Postal: 500034

More informations about "Suven Life Sciences"
Home - Suven Pharma
While building on this special capability and culture, we will enable our organization to rapidly scale to the next level. Towards this end, we will invest to upgrade on ESG (infrastructure, ...See details»
Board of Directors, Management & Advisory Council - Suven Pharma
Mr. Vivek Sharma has been appointed as the Executive Chairman of Suven, effective September 20, 2024, and will oversee the company's overall business operations, driving growth and โฆSee details»
Suven Life Sciences - Crunchbase Company Profile & Funding
When was the last funding round for Suven Life Sciences? Suven Life Sciences closed its last funding round on Dec 4, 2014 from a Post-IPO Equity round. Who are Suven Life Sciences 's โฆSee details»
Suven Life Sciences
Suven Life Sciences bags Pharmexcil's "Gold Patent Award" SUVN502 - Completed phase 1b clinical trial under US-IND. SUVNG3031 - Completed SAD and MAD studies of phase 1 โฆSee details»
Suven Life Sciences
Home; About Us; Background; Incorporated as a Privated Limited Company in 1989. Converted into a Public Limited Company in January 1995. Shares listed at Bombay Stock Exchange โฆSee details»
Suven Pharmaceuticals - Crunchbase Company Profile & Funding
Suven Pharmaceuticals offers formulation development services for various dosage forms, including solid orals, liquid orals, topical liquids, semi-solids, injections, sachets, and nano tech โฆSee details»
Suven Life Sciences Ltd. - Drug pipelines, Patents, Clinical
Jan 23, 2025 Explore Suven Life Sciences Ltd. with its drug pipeline, therapeutic area, technology platform, 13 clinical trials, 9 news, and 257 literature, Disease Domain:Nervous โฆSee details»
Suven Life Sciences - businessabc
Feb 25, 2025 Suven Life Sciences was established in 1990 as Venkatdescription, a proprietary research and development company. In 1995, the company changed its name to Suven โฆSee details»
About Us - Suven Pharma
Suven has established its core competency in cyanation and heterocyclic chemistry, including pyrimidines, quinolones, thiazoles, and imidazoles, in addition to demonstrating our proficiency โฆSee details»
Suven Pharma - PharmaSource
Suven Pharmaceuticals is a global pharmaceutical company specialising in drug development and manufacturing solutions for niche therapeutic areas. Based in India, Suven Pharmaceuticals is โฆSee details»
Advent-owned Suven Pharma to buy majority stake in NJ Bio for โฆ
Dec 9, 2024 Private equity giant Advent International-owned contract development and manufacturing organization (CDMO) Suven Pharma Saturday said it will acquire a controlling โฆSee details»
FAMILIARIZATION PROGRAMS FOR INDEPENDENT DIRECTORS
Suven Life Sciences Ltd (Suven) endeavors to organize various programs providing insights ... organization structure, finance, human resources, technology, quality, facilities and risk โฆSee details»
Suven Life Sciences Employee Reviews - Indeed
Dec 7, 2024 Reviews from Suven Life Sciences employees about Suven Life Sciences culture, salaries, benefits, work-life balance, management, job security, and more. ... Pleasure to work โฆSee details»
Business Segments - Suven Pharma
Suven Pharma is end-to-end Contract Development and Manufacturing Organization providing range of services, including: Development services โ development of new drugs, from early โฆSee details»
Suven doses first subjects in trial of SUVN-I6107 for cognitive โฆ
Jan 9, 2025 Suven has secured intellectual property rights for SUVN-I6107 in key markets globally. In addition to SUVN-I6107, Suvenโs clinical stage assets include Masupirdine (SUVN โฆSee details»
Suven Pharmaceuticals Limited: A Detailed Analysis of Growth โฆ
Mar 12, 2025 Suven Pharmaceuticals Limited, being an Indian Contract Development and Manufacturing Organization (CDMO), is a prominent global player in the pharmaceutical and โฆSee details»
Suven Pharmaceuticals - Craft
Oct 29, 2024 Suven Pharmaceuticals. Financials. Summary Financials. Revenue (Q1, 2025)โน2.3B Gross profit (Q1, 2025)โน1.9B Net income (Q1, 2025)โน607.7M Cash (FY, โฆSee details»
In preparation of Phase II studies, Right Brain Bio signs โฆ
Mar 11, 2025 "At Suven, we are thrilled to be part of this breakthrough initiative with Right Brain Bio," said Vivek Sharma, Executive Chairman of Suven Pharmaceuticals. "Our team is โฆSee details»
Suven Life Sciences
SUVEN believes that education is the passport to a better life. SUVEN wishes to encourage quality education to the weaker sections and least privileged people in its neighbourhood to โฆSee details»
Right Brain Bio to repurpose anticancer medication for Parkinsonโs
Mar 17, 2025 The company intends to file an application with the FDA asking for a green light to evaluate the therapyโs efficacy in slowing disease progression in Parkinsonโs patients. To โฆSee details»